Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) has issued an announcement.
Ab&B Bio-Tech CO., LTD. JS has announced the convening of its second extraordinary general meeting of 2025, scheduled for December 23, 2025. Key resolutions to be considered include the appointment of Mr. LI Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as the company’s auditors for the year 2025. This meeting will be accessible both on-site and online, allowing shareholders to participate and vote via the eVoting Portal, reflecting the company’s commitment to inclusive and transparent governance.
More about Ab&B Bio-Tech CO., LTD. JS Class H
Ab&B Bio-Tech CO., LTD. JS is a joint stock company established in the People’s Republic of China, operating within the biotechnology sector. The company is focused on developing and providing innovative biotech solutions, with a market focus on medical and high-tech zones.
Average Trading Volume: 204,773
Find detailed analytics on 2627 stock on TipRanks’ Stock Analysis page.